News

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
The main character 'Gwansik' in the recently popular Netflix drama 'I've been tricked' has died of multiple myeloma, making ...
Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...
Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...
A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...
New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer ...
Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...
Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...
Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...
Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 6.62%, which has investors questioning if this is right time to ...